Article · 12 Mar 2024
Research articlePublished 2014
Intraarticular Botulinum Toxin A for the Treatment of Painful Ankle Osteoarthritis-A Pilot Study
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Purpose: Ankle osteoarthritis (OA) can cause substantial pain and functional limitations. Effective therapy has been a key therapeutic challenge. The aim of this pilot study is to investigate the effects of intra articular Botulinum toxin type A (BoNT-A) for the treatment of patients with painful ankle OA. Methods: This was a prospective study conducted in a university-affiliated tertiary care medical center with 6- month follow-up. Patients with painful ankle OA for at least 6 months and radio graphically verified as having stage II OA according to the Kellgren-Lawrence classification were enrolled. Eligible patients received single intraarticular injections of BoNT-A (100 units). The primary outcome was the Ankle Osteoarthritis Scale (AOS) score at 6-month follow-up. Secondary outcomes measures included American Orthopaedic Foot and Ankle Society (AOFAS) ankle/ hindfoot score, Visual analog scale (VAS) for ankle pain, single leg stance test (SLS), Timed “Up-and-Go” test (TUG) and consumption of rescue analgesics. Patients were evaluated at baseline, 2 weeks, 1 month, 3 months, and 6 months post injection. Patients’ global satisfaction about therapy was assessed at 2 weeks, 1 month, 3 months, and 6 months post injection. Adverse events during the study period were recorded also. Results: Thirty-six patients completed the study. All patients showed significant improvements in AOS, AOFAS, VAS, SLS, TUG scores and consumption of rescue analgesics at 2 weeks, 1, 3 and 6 months respectively after the injection (p < 0.001 for each value compared with baseline). Patients’ global satisfaction rate was high with no serious adverse events. Conclusion: BoNT-A injection to the ankle joint is associated with improvement in pain, function and balance in patients with painful ankle OA. These effects can last for 6 months. This pilot study supports a possible role for BoNT-A as a treatment option for painful ankle OA. Future studies are needed to confirm the results.
Subjects
OrthopaedicsAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Arthritis.
Article · 18 Jan 2024
Investigating the Microrheological Properties of Knee Synovial Fluid by Means of the Multiple Tracking Technique
Article · 30 Sep 2023
Ankylosing spondylitis
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Arthritis
- SubjectOrthopaedics
- BylineArticles whose byline prints “I-Hsiu Liou”
- BylineArticles whose byline prints “Shu-Fen Sun”
- BylineArticles whose byline prints “Chien-Wei Hsu”
- BylineArticles whose byline prints “Huey-Shyan Lin”
- BylineArticles whose byline prints “Yi-Jiun Chou”
- BylineArticles whose byline prints “Hsien-Pin Sun”
- BylineArticles whose byline prints “Chen-Lun Lu”
- BylineArticles whose byline prints “Mei-Chia Chou”
